These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1002006)

  • 21. [Effect of daphnin on blood coagulation].
    Lakin KM; Kosheleva LI
    Farmakol Toksikol; 1968; 31(1):72-4. PubMed ID: 5675354
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of small doses of aspirin on thrombocyte aggregation].
    Ciko Z; Mijić R; Tanasijević M
    Vojnosanit Pregl; 1991; 48(3):211-5. PubMed ID: 1949660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid.
    Fager G; Cullberg M; Eriksson-Lepkowska M; Frison L; Eriksson UG
    Eur J Clin Pharmacol; 2003 Aug; 59(4):283-9. PubMed ID: 12845508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
    Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
    Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects.
    Tamminen M; Lassila R; Westerbacka J; Vehkavaara S; Yki-Järvinen H
    Int J Obes Relat Metab Disord; 2003 Aug; 27(8):907-11. PubMed ID: 12861231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of cytotoxic drugs on platelet functions and coagulation in vitro. IV. Melphalan.
    Klener P; Kubisz P; Suranová J
    Thromb Haemost; 1977 Feb; 37(1):53-61. PubMed ID: 576517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation of inhibitory effects of low-dose ASA on thromboxane production and platelet aggregation in ischemic stroke patients.
    Lee TK; Ng SK; Huang ZS; Chen YC
    J Formos Med Assoc; 1992 Sep; 91(9):891-7. PubMed ID: 1363390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiaggregation action and pharmacokinetics of lysine acetylsalicylate].
    Khadzhaĭ IaI; Chaĭka LA; Kosheleva LP; Libina VV; Pichugin VV
    Farmakol Toksikol; 1986; 49(4):58-62. PubMed ID: 3093269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylsalicylic acid and blood coagulation in the horse.
    Hagedorn HW; Böck M; Schulz R
    Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):410-2. PubMed ID: 1425318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet hyporesponsiveness to acetylsalicylic acid can be transferred by plasma in humans.
    Anger K; Kempfert J; Kostelka M; Mohr FW; Dhein S
    Pharmacology; 2010; 85(4):241-7. PubMed ID: 20332671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of simultaneous administration of low-dose heparin and acetylsalicylic acid on blood coagulation and platelet functions.
    Loew D; Vinazzer H
    Haemostasis; 1974; 3(5-6):319-28. PubMed ID: 4468231
    [No Abstract]   [Full Text] [Related]  

  • 32. Resistance to acetylsalicylic acid in patients after ischemic stroke.
    Zytkiewicz M; Giełwanowska L; Wojtasińska E; Psuja P; Zawilska K
    Pol Arch Med Wewn; 2008 Dec; 118(12):727-33. PubMed ID: 19202951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of platelet function analyzer PFA-100 and whole blood aggregometry to monitor blood platelet sensitivity to acetylsalicylic acid (aspirin). Is it possible to reliably monitor antiplatelet treatment using routine laboratory diagnostic methods?].
    Golański J; Chizyński K; Golański R; Watała C
    Pol Arch Med Wewn; 2000 Jul; 104(1):355-61. PubMed ID: 11303325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of different doses and different routes of acetylsalicylic acid administration on platelet aggregation in healthy volunteers and ischemic stroke patients.
    Chýlová M; Moťovská Z; Osmančík P; Procházka B; Kalvach P
    Transl Stroke Res; 2015 Apr; 6(2):160-5. PubMed ID: 25524214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet aggregation by acetylsalicylic acid and other inhibitors.
    Seuter F
    Haemostasis; 1976; 5(2):85-95. PubMed ID: 950178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, and acetylsalicylic acid.
    Hinder M; Frick A; Rosenburg R; Hesse G; Ozoux ML; Laux V; Scholtz H; Gebauer A; Paccaly A
    Thromb Haemost; 2006 Feb; 95(2):224-8. PubMed ID: 16493482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual variability of response and non-response to acetyl salicylic acid after cardiac surgery.
    Börgermann J; Kanashnik A; Sossdorf M; Gummert J; Lösche W
    Platelets; 2010; 21(8):610-5. PubMed ID: 20807171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 39. Biphasic initial phase of platelet aggregation inhibition after oral aspirin.
    Walter E; Zimmermann R; Siess R; Staiger C; Weber E
    Artery; 1980; 8(5):501-6. PubMed ID: 7213053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies.
    Perzborn E; Heitmeier S; Laux V
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):554-62. PubMed ID: 25848131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.